Vanda Pharmaceuticals Inc.
TREATMENT OF SCHIZOPHRENIA

Last updated:

Abstract:

Aspects of the invention relate generally to the treatment of schizophrenia and to monitoring for specific adverse reactions.

Status:
Application
Type:

Utility

Filling date:

28 Jun 2021

Issue date:

21 Oct 2021